Submit Deal

MEDICXI VENTURES

HQ - London

Summary

Medicxi is a venture capital firm that specializes in financing early-stage companies in the life sciences sector.

Deals Overview

Total Deals5

Valued Deals5

Total Value£ 1.61 B

Avg. Deal Size£ 321 M

Market Context

Senior Management

Francesco De Rubertis
Chairman
Giovanni Mariggi
Partner
Aaron Kantoff
Investor

Sort

16 Feb 2021|United Kingdom|Pharmaceuticals

Target: CENTESSA PHARMACEUTICALS

Bidder: JANUS HENDERSON INVESTORS

20 Service Providers

5 Target | 15 Bidder

27 Dealmakers

9 Target | 19 Bidder

£ 179 M

Value

22 Sep 2022|United States|Pharmaceuticals

Target: RIVUS PHARMACEUTICALS

Bidder: RA CAPITAL MANAGEMENT

8 Service Providers

2 Target | 6 Bidder

7 Dealmakers

1 Target | 6 Bidder

£ 116 M

Value

13 Feb 2024|United States|Biotechnology

Target: PROFOUNDBIO

Bidder: JANUS HENDERSON INVESTORS

3 Service Providers

2 Target | 1 Bidder

3 Dealmakers

2 Target | 1 Bidder

£ 88 M

Value

08 Apr 2024|China|Biotechnology

Target: D3 BIO

Bidder: MEDICXI VENTURES

3 Service Providers

2 Target | 1 Bidder

2 Dealmakers

1 Target | 1 Bidder

£ 31 M

Value

22 Jul 2025|United Kingdom|Biotechnology

Target: VICEBIO LTD

Bidder: SANOFI SA

7 Service Providers

3 Target | 2 Bidder | 2 Vendor

54 Dealmakers

28 Target | 24 Bidder | 2 Vendor

£ 1.19 B

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

Senior Management

Francesco De Rubertis
Chairman
Giovanni Mariggi
Partner
Aaron Kantoff
Investor